The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
The α4β2α5 nicotinic cholinergic receptor in rat brain is resistant to up‐regulation by nicotine in vivo
Abstract
We used immunoprecipitation with subunit-specific antibodies to examine the distribution of heteromeric neuronal nicotinic acetylcholine receptors (nAChRs) that contain the alpha5 subunit in the adult rat brain. Among the regions of brain we surveyed, the alpha5 subunit is associated in approximately 37% of the nAChRs in the hippocampus, approximately 24% of the nAChRs in striatum, and 11-16% of the receptors in the cerebral cortex, thalamus, and superior colliculus. Sequential immunoprecipitation assays demonstrate that the alpha5 subunit is associated with alpha4beta2* nAChRs exclusively. Importantly, in contrast to alpha4beta2 nAChRs, which are increased by 37-85% after chronic administration of nicotine, the alpha4beta2alpha5 receptors are not increased by nicotine treatment. These data thus indicate that the alpha4beta2alpha5 nAChRs in rat brain are resistant to up-regulation by nicotine in vivo, which suggests an important regulatory role for the alpha5 subunit. To the extent that nicotine-induced up-regulation of alpha4beta2 nAChRs is involved in nicotine addiction, the resistance of the alpha4beta2alpha5 subtype to up-regulation may have important implications for nicotine addiction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, different β2*-subunit combinations appear to be differentially regulated by nicotine, with α3/α6 and α6α4β2* and α5α4β2* not upregulating or decreasing in response to nicotine38, 85-88 while α6β2 (nonα4) nAChR increase in response to nicotine88.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [38]
In the citing paper
“For example, the presence of α5 renders α4β2* nAChRs insensitive to nicotine-induced upregulation (Mao et al. 2008).”
From Nicotine Withdrawal (2015) · cites this paper as Mao et al. 2008
In the citing paper
“Immunoprecipitation with subunit-selective antibodies and studies in genetic knockout models demonstrate that chronic administration of nicotine increases predominantly the ␣42 subtype of nAChRs in rodent brain (Flores et al., 1992;Mao et al., 2008;Moretti et al., 2010;Marks et al., 2011)”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Mao et al., 2008
In the citing paper
“While this prediction is straightforward, testing it has been confounded by the observation that different brain regions and nAChR subtypes have different upregulation parameters (Collins et al., 1989; Mao et al., 2008; Perry et al., 2007) and a lack of understanding of which brain regions are critically involved in specific withdrawal symptoms.”
From The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation (2012) · cites this paper as Mao et al., 2008
In the citing paper
“Recent data indicate that the α5 subunit modifies upregulation of α4β2* receptors (112) and Lindstrom speculates that the effect proceeds at the level of chaperoning (113).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [112]
Citations
Cites
Data Reduction and Error Analysis for the Physical Sciences
Bevington, P. R., Robinson, D. K., Blair, J. M., Mallinckrodt, A. J., & McKay, S. R. (1993) · Computers in Physics · doi:10.1063/1.4823194 · Cited by 15,003
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins
Karlin, A., & Akabas, M. H. (1995) · Neuron · doi:10.1016/0896-6273(95)90004-7 · Cited by 622
Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain
Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 512
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479
Self-citationEffects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464
Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407
Cited by
Sorted by citations
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
The dynamic effects of nicotine on the developing brain
Dwyer, J. B., McQuown, S. C., & Leslie, F. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.003 · Cited by 559
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 543
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338
Diversity of native nicotinic receptor subtypes in mammalian brain
Zoli, M., Pistillo, F., & Gotti, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.003 · Cited by 277
Smoking, nicotine and neuropsychiatric disorders
Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 227
Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses
Miwa, J. M., Freedman, R., & Lester, H. A. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.014 · Cited by 205
Roles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195
Wang, J. C. C., Cruchaga, C., Saccone, N. L., Bertelsen, S. E., Liu, P., Budde, J., Duan, W., Fox, L. W., Grucza, R. A., Kern, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp231 · Cited by 194
Kuryatov, A., Berrettini, W., & Lindstrom, J. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.066357 · Cited by 171
McLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 191
Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability
Fowler, C. D., & Kenny, P. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.008 · Cited by 176
Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163
Cosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 165
Jackson, K. J., Marks, M. J., Vann, R. E., Chen, X., Gamage, T. F., Warner, J. A., & Damaj, M. I. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165738 · Cited by 156
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
The Nicotinic Acetylcholine Receptor 5 Subunit Plays a Key Role in Attention Circuitry and Accuracy
Bailey, C. D. C., De Biasi, M., Fletcher, P. J., & Lambe, E. K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2258-10.2010 · Cited by 146
Assembly and trafficking of nicotinic acetylcholine receptors (Review)
Millar, N. S., & Harkness, P. C. (2008) · Molecular Membrane Biology · doi:10.1080/09687680802035675 · Cited by 143
Doura, M. B., Gold, A. B., Keller, A. B., & Perry, D. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.056 · Cited by 129
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Xiao, C., Zhou, C., Jiang, J., & Cui, Y. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0299-4 · Cited by 124
Biogenesis, trafficking and up-regulation of nicotinic ACh receptors
Colombo, S. F., Mazzo, F., Pistillo, F., & Gotti, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.023 · Cited by 121
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 112
Huang, L. Z., Parameswaran, N., Bordia, T., McIntosh, J. M., & Quik, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06011.x · Cited by 94
The Biological Impact of Menthol on Tobacco Dependence
Wickham, R. J. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz239 · Cited by 86
Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77
An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants
Baddick, C. G., & Marks, M. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.019 · Cited by 75
Greenbaum, L., & Lerer, B. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.59 · Cited by 73
Marks, M. J., McClure-Begley, T. D., Whiteaker, P., Salminen, O., Brown, R. W. B., Cooper, J., Collins, A. C., & Lindstrom, J. M. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178236 · Cited by 70
Bailey, C. D. C., Alves, N. C., Nashmi, R., De Biasi, M., & Lambe, E. K. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.011 · Cited by 69
Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning
Gould, T. J., & Leach, P. T. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.08.004 · Cited by 72
Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's disease
Srinivasan, R., Henderson, B. J., Lester, H. A., & Richards, C. I. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.02.005 · Cited by 67
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.
Raybuck, J. D., Portugal, G. S., Lerman, C., & Gould, T. J. (2008) · Behavioral Neuroscience · doi:10.1037/a0012601 · Cited by 62
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Bağdaş, D., AlSharari, S. D., Freitas, K., Tracy, M. E., & Damaj, M. I. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.013 · Cited by 64
Proulx, É., Piva, M., Tian, M. K., Bailey, C. D. C., & Lambe, E. K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1481-3 · Cited by 66
Moretti, M., Mugnaini, M., Tessari, M., Zoli, M., Gaimarri, A., Manfredi, I., Pistillo, F., Clementi, F., & Gotti, C. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064071 · Cited by 58
Function of Human α3β4α5 Nicotinic Acetylcholine Receptors Is Reduced by the α5(D398N) Variant
George, A. A., Lucero, L. M., Damaj, M. I., Lukas, R. J., Chen, X., & Whiteaker, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.379339 · Cited by 60
Paying attention to smell: cholinergic signaling in the olfactory bulb
Dâ€TMSouza, R. D., & Vijayaraghavan, S. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00021 · Cited by 57
Gould, T. J., Portugal, G. S., André, J. M., Tadman, M. P., Marks, M. J., Kenney, J. W., Yildirim, E., & Adoff, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.003 · Cited by 56
“…it has been confounded by the observation that different brain regions and nAChR subtypes have different upregulation parameters (Collins et al., 1989; Mao et al., 2008; Perry et al., 2007) and a lack of understanding of which brain regions are critically involved in specific withdrawal symptoms.”
Nicotinic receptor-based therapeutics and candidates for smoking cessation
Dwoskin, L. P., Smith, A. M., Wooters, T. E., Zhang, Z., Crooks, P. A., & Bardo, M. T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.002 · Cited by 57
Nicotinic acetylcholine receptors: upregulation, age‐related effects and associations with drug use
Melroy-Greif, W. E., Stitzel, J. A., & Ehringer, M. A. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12251 · Cited by 58
Grupe, M., Grunnet, M., Bastlund, J. F., & Jensen, A. A. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12361 · Cited by 54
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia
Wecker, L., Engberg, M. E., Philpot, R. M., Lambert, C. S., Kang, C. W., Antilla, J. C., Bickford, P. C., Hudson, C. E., Zesiewicz, T. A., & Rowell, P. P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.016 · Cited by 46
The Role of Nicotine in Schizophrenia
Featherstone, R. E., & Siegel, S. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.07.002 · Cited by 47
AlSharari, S. D., Carroll, F. I., McIntosh, J. M., & Damaj, M. I. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194506 · Cited by 43
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
Gold, A. B., & Lerman, C. E. (2012) · Human Genetics · doi:10.1007/s00439-012-1143-9 · Cited by 41
Santos, N., Chatterjee, S., Henry, A., Holgate, J. Y., & Bartlett, S. E. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12009 · Cited by 40
Nicotinic alteration of decision-making
Naudé, J., Dongelmans, M., & Faure, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.021 · Cited by 39
van der Zee, E. A., & Keijser, J. N. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.051 · Cited by 39
Chatterjee, S., Santos, N., Holgate, J. Y., Haass‐Koffler, C. L., Hopf, F. W., Kharazia, V., Lester, H. A., Bonci, A., & Bartlett, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068300 · Cited by 41
Lomazzo, E., Hussmann, G. P., Wolfe, B. B., Yasuda, R. P., Perry, D. C., & Kellar, K. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07408.x · Cited by 37
Self-citationMechanisms of GABAergic and cholinergic neurotransmission in auditory thalamus: Impact of aging
Richardson, B. D., Sottile, S. Y., & Caspary, D. M. (2020) · Hearing Research · doi:10.1016/j.heares.2020.108003 · Cited by 37
Marks, M. J., Grady, S. R., Salminen, O., Paley, M. A., Wageman, C. R., McIntosh, J. M., & Whiteaker, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12721 · Cited by 37
Cox, B. C., Marritt, A. M., Perry, D. C., & Kellar, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05282.x · Cited by 43
Hussmann, G. P., Turner, J. R., Lomazzo, E., Venkatesh, R., Cousins, V., Xiao, Y., Yasuda, R. P., Wolfe, B. B., Perry, D. C., Rezvani, A. H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.198085 · Cited by 34
Marks, M. J., Meinerz, N. M., Brown, R. W. B., & Collins, A. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.040 · Cited by 33
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 33
Dau, A., Komal, P., Truong, M., Morris, G., Evans, G., & Nashmi, R. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-47 · Cited by 33
Fasoli, F., Moretti, M., Zoli, M., Pistillo, F., Crespi, A., Clementi, F., McClure‐Begley, T. D., Marks, M. J., & Gotti, C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.048 · Cited by 34
The α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2* and α3β4* Receptors
Scholze, P., & Huck, S. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.607959 · Cited by 33
Jain, A., Kuryatov, A., Wang, J., Kamenecka, T. M., & Lindstrom, J. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749150 · Cited by 31
Jin, X., Bermúdez, I., & Steinbach, J. H. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.089979 · Cited by 28
Effect of the Rs1051730–Rs16969968 Variant and Smoking Cessation Treatment: A Meta-Analysis
Leung, T., Bergen, A. W., Munafo, M. R., Ruyck, K. D., Selby, P. L., & Luca, V. D. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.34 · Cited by 29
Impact of ageing on postsynaptic neuronal nicotinic neurotransmission in auditory thalamus
Sottile, S. Y., Ling, L. L., Cox, B. C., & Caspary, D. M. (2017) · The Journal of Physiology · doi:10.1113/jp274467 · Cited by 27
Enhanced Sensory–Cognitive Processing by Activation of Nicotinic Acetylcholine Receptors
Gil, S. M., & Metherate, R. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty134 · Cited by 29
Brain Region Specific Single-Molecule Fluorescence Imaging
Fu, X., Moonschi, F. H., Fox-Loe, A. M., Snell, A. A., Hopkins, D. M., Avelar, A. J., Henderson, B. J., Pauly, J. R., & Richards, C. I. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02133 · Cited by 25
Hone, A. J., Whiteaker, P., Mohn, J. L., Jacob, M. H., & McIntosh, J. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06819.x · Cited by 26
Zhang, J., Xiao, Y.-D., Green-Jordan, K., Hammond, P. S., Dyke, K. M. V., Mazurov, A. A., Speake, J. D., Lippiello, P. M., James, J. W., Letchworth, S. R., et al. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.09.014 · Cited by 26
Li, P., McCollum, M. M., Bracamontes, J. R., Steinbach, J. H., & Akk, G. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073841 · Cited by 25
Ghimire, M., Cai, R., Ling, L. L., Hackett, T. A., & Caspary, D. M. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0093-20.2020 · Cited by 25
Subunit composition of α5‐containing nicotinic receptors in the rodent habenula
Scholze, P., Koth, G., Orr‐Urtreger, A., & Huck, S. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07714.x · Cited by 25
DeDominicis, K. E., Sahibzada, N., Olson, T. T., Xiao, Y., Wolfe, B. B., Kellar, K. J., & Yasuda, R. P. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.106880 · Cited by 24
Bailey, C. D. C., Tian, M. K., Kang, L., O’Reilly, R., & Lambe, E. K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.003 · Cited by 24
Hussmann, G. P., DeDominicis, K. E., Turner, J. R., Yasuda, R. P., Klehm, J., Forcelli, P. A., Xiao, Y., Richardson, J. R., Sahibzada, N., Wolfe, B. B., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12653 · Cited by 23
Tobey, K. M., Walentiny, D. M., Wiley, J. L., Carroll, F. I., Damaj, M. I., Azar, M. R., Koob, G. F., George, O., Harris, L. S., & Vann, R. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2703-3 · Cited by 23
Hoegberg, B. G., Lomazzo, E., Lee, N. H., & Perry, D. C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.015 · Cited by 17
Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity
Wilking, J. A., Hesterberg, K. G., Crouch, E. L., Homanics, G. E., & Stitzel, J. A. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283369347 · Cited by 20
Gözen, O., Nesil, T., Kanıt, L., Koylu, E. O., & Pöğün, Ş. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1198799 · Cited by 17
Wageman, C. R., Marks, M. J., & Grady, S. R. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt146 · Cited by 16
Hussmann, G. P., Yasuda, R. P., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289546 · Cited by 16
Quantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus
Lomazzo, E., MacArthur, L. H., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06967.x · Cited by 15
Pubill, D., Garcia‐Ratés, S., Camarasa, J., & Escubedo, E. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.11.008 · Cited by 15
Chung, B. Y. T., Bignell, W., Jacklin, D. L., Winters, B. D., & Bailey, C. D. C. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00370.2016 · Cited by 15
Smith, A. M., Pivavarchyk, M., Wooters, T. E., Zhang, Z., Zheng, G., McIntosh, J. M., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.018 · Cited by 15
Choline Promotes Nicotinic Receptor α4 + β2 Up-regulation
Gahring, L. C., Vasquez-Opazo, G. A., & Rogers, S. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108803 · Cited by 16
Yang, K., McLaughlin, I., Shaw, J. K., Cardé, N. A. Q., Dani, J. A., & Biasi, M. D. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109547 · Cited by 12
Evidence for the role of β2* nAChR desensitization in regulating body weight in obese mice
Dezfuli, G., Kellar, K. J., Dretchen, K. L., Tizabi, Y., Sahibzada, N., & Gillis, R. A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.020 · Cited by 13
Gahring, L. C., & Rogers, S. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105346 · Cited by 12
Semenova, S., Jin, X., McClure‐Begley, T. D., Tadman, M. P., Marks, M. J., & Markou, A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.06.002 · Cited by 13
Cardé, N. A. Q., Shaw, J. K., Carter, C., Kim, S., Stitzel, J. A., Venkatesh, S. K., Ramchandani, V. A., & Biasi, M. D. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109170 · Cited by 10
Role of α5-containing nicotinic receptors in neuropathic pain and response to nicotine
Xanthos, D. N., Beiersdorf, J., Thrun, A., Ianosi, B., Orr‐Urtreger, A., Huck, S., & Scholze, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.012 · Cited by 11
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
Moerke, M. J., McMahon, L. R., & Wilkerson, J. L. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018028 · Cited by 11
Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms
Brynildsen, J. K., & Blendy, J. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108480 · Cited by 11
Nagumo, Y., Takeuchi, Y., Imoto, K., & Miyata, M. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.12.002 · Cited by 9
Tuan, E. W., Horti, A. G., Olson, T. T., Gao, Y., Stockmeier, C. A., Al‐Muhtasib, N., Dalley, C. B., Lewin, A. E., Wolfe, B. B., Sahibzada, N., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099978 · Cited by 9
Bağdaş, D., AlSharari, S. D., Roni, M. A., Campbell, V. C., Muldoon, P. P., Carroll, F. I., & Damaj, M. I. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.027 · Cited by 9
Moretti, M., Fasoli, F., Gotti, C., & Marks, M. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13896 · Cited by 8
Rooy, M., Lazarevich, I. A., Koukouli, F., Maskos, U., & Gutkin, B. S. (2021) · Current Research in Neurobiology · doi:10.1016/j.crneur.2021.100018 · Cited by 7
Metadata
- Authors
- Mao, D., Perry, D. C., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J.
- Affiliations
- Georgetown University (US)
- George Washington University (US)
- Corresponding author
- Kellar, Kenneth J.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-09-26
- Volume
- 104
- Issue
- 2
- Pages
- 446-456
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1976309270
- Cited by
- 133
- References
- 57
- Citations by year
- 2026: 3 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 11 · 2015: 11 · 2014: 11 · 2013: 12 · 2012: 14
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (R01DA015767, DA015767, DA 12976)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotinic acetylcholine receptors, alpha5 subunit, receptor up-regulation, nicotine, receptor subunit composition, hippocampus, striatum, cerebral cortex, thalamus, superior colliculus, nicotine dependence, rat brain
- MeSH terms
- Animals, Binding Sites, Brain, Nicotine, Pyridines, Receptors, Nicotinic, Up-Regulation, Rats, Sprague-Dawley, Nicotinic Agonists, Bridged Bicyclo Compounds, Heterocyclic, Protein Subunits, Immunoprecipitation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review